- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03026413
The Comparison Between the PVAM and CPVI for the Patients of PAF (FORCE-PVA)
July 19, 2018 updated by: Minglong Chen, The First Affiliated Hospital with Nanjing Medical University
The Comparison Between the Pulmonary Vein Antrum Modification by SmartTouch Ablation Catheter With Contact Force Monitoring and Circumferential Pulmonary Vein Isolation by That Without Contact Force Monitoring Plus Lasso Catheter for the Patients of Paroxysmal Atrial Fibrillation: a Randomized Controlled Trial
To compare the efficacy and safety of circumferential pulmonary vein isolation without contact force with the pulmonary vein antrum modification for patients of paroxysmal atrial fibrillation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single centre, prospective control study.
The study will enroll 180 patients with 2:1 grouped.
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with paroxysmal atrial fibrillation refractory to drugs
- with consent
Exclusion Criteria:
- LVEF<50%
- history of cardiac surgery
- valvular heart disease
- abnormal thyroid function
- left atrial thrombus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PVAM
pulomonary vein antrum modification with contact force monitoring for AF
|
|
Active Comparator: Control arm
pulmonary vein isolation without contact force
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
any recorded atrial arrhythmias proved by 7-day holter
Time Frame: at least 18 months follow up
|
sustained at least 30s
|
at least 18 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
procedure time
Time Frame: time during patient enrollment
|
time that the patient spend in the procedure room
|
time during patient enrollment
|
x ray time
Time Frame: time during patient enrollment
|
x ray spent during the procedure
|
time during patient enrollment
|
adverse event
Time Frame: at least 18 months follow up
|
at least 18 months follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, Lambert H, Yulzari A, Wissner E, Kuck KH. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):327-33. doi: 10.1161/CIRCEP.113.000374. Epub 2013 Mar 20.
- Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jais P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm. 2012 Nov;9(11):1789-95. doi: 10.1016/j.hrthm.2012.07.016. Epub 2012 Jul 20.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
December 27, 2016
First Submitted That Met QC Criteria
January 17, 2017
First Posted (Estimate)
January 20, 2017
Study Record Updates
Last Update Posted (Actual)
July 20, 2018
Last Update Submitted That Met QC Criteria
July 19, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NJ01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
Beijing Anzhen HospitalJohnson & Johnson; Heart Health Research CenterNot yet recruitingParoxysmal Atrial Fibrillation | Persistent Atrial Fibrillation
-
Maastricht UniversityRadboud University Medical Center; Maastricht University Medical CenterRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Atrial Fibrillation ParoxysmalNetherlands
-
Cardialen, Inc.Iqvia Pty Ltd; AvaniaTerminatedAtrial Fibrillation | Atrial Fibrillation, Persistent | Atrial Fibrillation, ParoxysmalAustralia
Clinical Trials on pulmonary vein antrum modification
-
McGill University Health Centre/Research Institute...Montreal Heart InstituteRecruitingAtrial FibrillationBelgium, Canada, France, Japan, Australia, Austria, United States, Italy
-
Texas Cardiac Arrhythmia Research FoundationRCCS Monzino Hospital, Milan, Italy; Ospedale dell'Angelo, Venezia-MestreUnknownPersistent Atrial Fibrillation | Long-standing Persistent Atrial FibrillationUnited States
-
Texas Cardiac Arrhythmia Research FoundationCatholic University of the Sacred Heart; Capital Medical University; Centro Cardiologico...Completed
-
The Second Affiliated Hospital of Chongqing Medical...UnknownAtrial FibrillationChina
-
Centro Medico TeknonCompleted
-
Liverpool Heart and Chest Hospital NHS Foundation...UnknownAtrial FibrillationUnited Kingdom
-
Texas Cardiac Arrhythmia Research FoundationCalifornia Pacific Medical CenterUnknownAtrial FibrillationUnited States
-
University of LeipzigRecruiting
-
Hospital Clinic of BarcelonaCompletedDrug-refractory Paroxysmal Atrial FibrillationSpain
-
University Medical Center GoettingenStereotaxisCompletedPulmonary Vein Isolation, Ablation Time, Procedure Time, Freedom Form Atrial FibrillationGermany